$GTCH "We are quite ambitions when it comes to our

$GTCH "We are quite ambitions when it comes to our qTerm health watching device and constantly looking how to make it more comprehensive and efficient. Using the device optical sensors along with advanced artificial intelligence analytics, we are aiming to provide noninvasive blood glucose data simply with the touch of a finger. The hardware will sample blood elements data, providing it to a set of AI algorithms to conclude glucose levels. We believe this type of check, assuming fully developed, will be very appealing for diabetic patients due to its simplicity and noninvasive fashion. We strongly believe that this additional feature, if successfully developed, can be a major asset to qTerm, making it a comprehensive health watching device to assist with a healthy lifestyle,” said Danny Rittman, the Company CTO.